Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Radioimmunotherapy (RIT) in MULTIPLE MYELOMA Using the Antibody B-B4 Radiolabelled With IODE 131
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of the Spectra Optia® Mononuclear Cell Collection Procedure
- Status
- COMPLETED
- Phase
- NA
Effect of Eltrombopag Plus G-CSF on Human CD34+ Cell Mobilization in Multiple Myeloma Patients Undergoing ASCT
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Velcade Consolidation Bone Study
- Status
- COMPLETED
- Phase
- PHASE2
Cyclophosphamide as Sole Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
A Randomized Study With Oral Melphalan + Prednisone (MP) Versus Melphalan, + Prednisone + Thalidomide (MPT) for Newly Diagnosesd Elderly Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Nonmyeloablative Allogeneic Transplant
- Status
- COMPLETED
- Phase
- NA
Lenalidomide & High Dose Dexamethasone for Untreated Multiple Myeloma Renal Failure Patients
- Status
- COMPLETED
- Phase
- PHASE2
Role of BCL-B in Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients
- Status
- WITHDRAWN
- Phase
- PHASE2
Preventive Treatment of VETD in Patients With Multiple Myeloma Receiving Chemotherapy With Thalidomide or Lenalinomide.
- Status
- COMPLETED
- Phase
- N/A
A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE3
Safety And Efficacy Of Lenalidomide As Maintenance Therapy In Patients With Newly Diagnosed Multiple Myeloma Following A Tandem Autologous-Allogeneic Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Sequential High-dose Dexamethasone and Response Adopted PAD or VAD Induction Chemotherapy Followed by High-dose Chemotherapy With Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Dose Escalation Trial of Denileukin Diftitox (Ontak) Post Autologous Transplantation
- Status
- TERMINATED
- Phase
- PHASE1
Technology Platform and System Construction of Clinical Evaluation Studies on New Drugs of Hematological Malignancy
- Status
- AVAILABLE
- Phase
- N/A
Efficacy Study of PAD and TAD in Newly Diagnosed Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE4
A Phase II Trial of Anti-KIR in Smoldering Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Carfilzomib, Pegylated Liposomal Doxorubicin Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2